Valorisation-Recherche, Societe En Commandite
Records under this name other than patents Valorisation-Recherche, Societe En Commandite holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Valorisation-Recherche, Societe En Commandite
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,618,054 | Interleukin-1 receptor antagonists, compositions, and methods of treatment Formerly held Term ended Term ended Sep 29, 2025 · From the USPTO record | Term ended | Term ended Sep 29, 2025 | From the USPTO record |
| US 7,445,782 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases Formerly held Term ended Term ended May 21, 2022 · From the USPTO record | Term ended | Term ended May 21, 2022 | From the USPTO record |
| US 7,727,531 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases Term ended Term ended Mar 14, 2022 · From the USPTO record | Term ended | Term ended Mar 14, 2022 | From the USPTO record |
| US 8,623,372 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases Term ended Ended no later than Mar 14, 2022 · From the USPTO record | Term ended | Ended no later than Mar 14, 2022 | From the USPTO record |
| US 8,202,847 | Mutant Human CD80 and Compositions for and Methods of Making and Using the Same Term ended Term ended Apr 10, 2021 · Medium confidence | Term ended | Term ended Apr 10, 2021 | Medium confidence |
| US 7,446,189 | Nucleic acids encoding mutant human CD80 and compositions comprising the same Term ended Term ended Apr 27, 2020 · From the USPTO record | Term ended | Term ended Apr 27, 2020 | From the USPTO record |
| US 7,785,567 | Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia Formerly held Lapsed on the fee record Ended Aug 31, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 31, 2018 | From the USPTO record |
| US 7,851,178 | Biological indicators for validating a prion sterilization-process Lapsed on the fee record Ended Dec 14, 2014 · From the USPTO record | Lapsed on the fee record | Ended Dec 14, 2014 | From the USPTO record |
| US 7,432,341 | Cytokine receptor modulators and method of modulating cytokine receptor activity Formerly held Lapsed on the fee record Ended Oct 7, 2012 · From the USPTO record | Lapsed on the fee record | Ended Oct 7, 2012 | From the USPTO record |